News Reports Highlight Scientific Findings Presented At AIDS 2014

News outlets highlight several of the scientific findings presented this week at the 20th International AIDS Conference in Melbourne, Australia. Making Strides: Highlights of Research Unveiled at AIDS Conference
“Coinciding with the 2014 International AIDS Conference, the Journal of the American Medical Association (JAMA) released a special theme issue this month that highlights the major research and studies presented…” (Tietjen, 7/24).

Herald Sun: Drug hope on reducing HIV levels hidden in cells, hears Melbourne AIDS Conference
“Australian scientists have developed a drug that not only shows promise in reducing HIV levels hidden in cells, but can lessen the impact the virus has on the immune system…” (Van Den Berg/O’Connell, 7/23).

The Guardian: HIV discovery reveals virus hidden in immune system cells
“Danish researchers have used an anti-cancer medicine to activate HIV hidden in the cells of patients taking anti-HIV drugs, exposing the virus to the immune system and making it susceptible to attack…” (Davey, 7/22).

Reuters: Celgene drug can drive HIV out of hiding: study
“An anti-cancer drug made by the U.S. biotech firm Celgene can re-activate hidden HIV in patients so that it can be detected, bringing researchers closer to being able to treat it, Danish scientists said on Tuesday…” (Kelland, 7/22).

Associated Press: HIV pills show more promise to prevent infection
“There is more good news about HIV treatment pills used to prevent infection in people at high risk of getting the AIDS virus: Follow-up from a landmark study that proved the drug works now shows that it does not encourage risky sex and is effective even if people skip some doses…” (7/22).

Bloomberg News: Shorter Treatment for Tuberculosis Works in HIV Patients
“A three-drug combo that includes an experimental treatment from the Global Alliance for TB Drug Development may cure tuberculosis more quickly than current regimens, a study found, offering new hope to patients with HIV…” (French, 7/22).

Los Angeles Times: More bad news in fight against persistent HIV reservoirs
“…On Monday, a study published in Annals of Internal Medicine found that two HIV patients who were given ‘new’ immune systems in the form of bone marrow transplants suffered renewed HIV infection after initially testing negative for the disease…” (Morin, 7/21).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.